Lifevantage (NASDAQ:LFVN) Stock Price Crosses Below 200-Day Moving Average After Analyst Downgrade

Posted by Geri Gentry on Oct 21st, 2026

Lifevantage Corporation (NASDAQ:LFVN – Get Free Report)’s stock price passed below its 200-day moving average during trading on Monday after Zacks Research downgraded the stock from a hold rating to a strong sell rating. The stock has a 200-day moving average of $6.20 and traded as low as $5.94. Lifevantage shares last traded at $5.98, with a volume of 26,980 shares traded.

A number of other brokerages have also weighed in on LFVN. Lake Street Capital upped their target price on Lifevantage from $5.00 to $6.00 and gave the stock a “hold” rating in a research note on Friday, August 28th. Weiss Ratings restated a “hold (c)” rating on shares of Lifevantage in a research report on Friday, August 21st. Two research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Reduce” and an average target price of $5.50.

View Our Latest Analysis on Lifevantage

Insiders Place Their Bets

In other Lifevantage news, insider Kristen Cunningham sold 8,901 shares of the firm’s stock in a transaction dated Monday, September 14th. The stock was sold at an average price of $6.18, for a total transaction of $55,008.18. Following the sale, the insider owned 120,162 shares in the company, valued at $742,601.16. This trade represents a 6.90% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 13.58% of the stock is owned by insiders.

Hedge Funds Weigh In On Lifevantage

Several institutional investors have recently modified their holdings of the company. Engineers Gate Manager LP lifted its position in Lifevantage by 109.7% in the 2nd quarter. Engineers Gate Manager LP now owns 27,009 shares of the company’s stock worth $169,000 after buying an additional 14,131 shares during the last quarter. Bank of New York Mellon Corp boosted its stake in Lifevantage by 11.9% in the first quarter. Bank of New York Mellon Corp now owns 33,547 shares of the company’s stock worth $145,000 after buying an additional 3,571 shares in the last quarter. Bank of America Corp DE grew its position in Lifevantage by 24.3% during the first quarter. Bank of America Corp DE now owns 23,445 shares of the company’s stock valued at $101,000 after acquiring an additional 4,586 shares during the last quarter. Hsbc Holdings PLC bought a new position in Lifevantage during the first quarter valued at approximately $51,000. Finally, DGS Capital Management LLC bought a new position in Lifevantage during the first quarter valued at approximately $44,000. 35.32% of the stock is currently owned by institutional investors.

Lifevantage Price Performance

The stock has a market capitalization of $74.91 million, a PE ratio of 14.88 and a beta of 0.68. The firm’s 50 day simple moving average is $6.27 and its 200 day simple moving average is $6.21.

Lifevantage (NASDAQ:LFVN – Get Free Report) last released its earnings results on Thursday, August 27th. The company reported $0.11 EPS for the quarter, missing the consensus estimate of $0.12 by ($0.01). Lifevantage had a net margin of 2.78% and a return on equity of 21.56%. The business had revenue of $42.38 million for the quarter, compared to the consensus estimate of $44.00 million. Analysts expect that Lifevantage Corporation will post 0.39 earnings per share for the current fiscal year.

Lifevantage Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st were paid a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a dividend yield of 3.4%. The ex-dividend date of this dividend was Tuesday, September 1st. Lifevantage’s dividend payout ratio is 50.00%.

About Lifevantage

(Get Free Report)

LifeVantage Corporation is a health and wellness company that develops, markets and distributes nutritional supplements, skincare products and other wellness solutions. Its products are designed to support areas such as cellular health, energy, healthy aging and skin care.

The company’s product portfolio has included the Protandim line of dietary supplements, TrueScience skincare products and AXIO energy and wellness products. LifeVantage sells primarily through a direct-selling model, supported by independent distributors, as well as through digital commerce and other retail channels.

Founded in 2003 and headquartered in Lehi, Utah, LifeVantage serves customers in the United States and selected international markets, including Japan, Australia and Hong Kong.